Submitted by Anonymous (not verified) on 30 August 2024 - 14:40
Human medicines European public assessment report (EPAR): Saphnelo, anifrolumab, Date of authorisation: 14/02/2022, Revision: 7, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Saphnelo, anifrolumab, Date of authorisation: 14/02/2022, Revision: 7, Status: Authorised